What's happening with the ResMed share price on Wednesday?

The ResMed share price is facing some quarterly headwinds today.

| More on:
Hand with Australian dollar notes handing the money to another hand symbolising ex-dividend date.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The ResMed Inc (ASX: RMD) share price is edging higher today.

Shares in the S&P/ASX 200 Index (ASX: XJO) healthcare stock closed yesterday trading for $29.30. In morning trade on Wednesday, shares are swapping hands for $29.34, up 0.1%.

For some context, the ASX 200 is up 0.6% at this same time.

Here's what's happening.

What's going on with the ASX 200 healthcare company?

The ResMed share price may be trailing the ASX 200 because the sleep treatment company's stock is trading ex-dividend today.

That means investors who buy the stock today will no longer be eligible for the 4.8 US cents per share unfranked dividend.

That passive income payout will go to investors who held ResMed shares at market close yesterday. Eligible investors can expect to see this hit their bank accounts on 14 March.

The company will report on the Aussie dollar equivalent for ASX investors on Friday, 9 February. (At time of writing AU$1 is worth 65.3 US cents.)

It's common for stocks to face some headwinds on the day they trade ex-dividend. All else being equal, the ResMed share price is now factored in at 4.8 US cents less than it would have been yesterday.

Unlike most ASX 200 stocks, ResMed pays dividends on a quarterly basis.

In the quarter just past, the company paid US$70.7 million in dividends. It also repurchased 335,000 shares for US$50 million as part of ResMed's ongoing capital management.

Overall, it was a strong quarter for the company, with revenue up 12% year on year (11% on a constant currency basis) to US$1.2 billion. And profits were well up, with non-GAAP operating profit leaping 20%.

Commenting on the outlook for the sleep treatment company on the day it reported, CEO Mick Farrell said, "ResMed is well-positioned to lean into leading the expansion and growth of sleep health and breathing health. We are the clear leader in a very large and growing market."

ResMed share price snapshot

The steep falls in August and September see the ResMed share price down 7% over 12 months.

Shares have soared 37% since the lows on 25 September.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Dividend Investing

A man looks at his laptop waiting in anticipation.
Dividend Investing

A 3.5% ASX dividend stock paying cash every month

Some monthly divided stocks are more equal than others.

Read more »

A man smiles as he holds bank notes in front of a laptop.
Dividend Investing

3 of the best ASX dividend stocks to buy now

Let's see which dividend stocks analysts are tipping as buys.

Read more »

Close-up of a business man's hand stacking gold coins into piles on a desktop.
Dividend Investing

3 great ASX dividend shares to buy in 2026

These are the types of dividend investments that Australians should look at.

Read more »

Happy young woman saving money in a piggy bank.
Dividend Investing

2 ASX income stocks with 6% dividend yields I would buy

High yields only matter if the income can be maintained. These two ASX stocks offer visible cash flows and dependable…

Read more »

A man wearing a suit and holding a colourful umbrella over his head purses his lips as though he has just found out some interesting news.
Financial Shares

Looking at the IAG share price? Here's how much this stock pays in dividends

Despite a rough year, 2025 saw IAG hike its dividends substantially.

Read more »

A red heart-shaped balloon float up above the plain white ones, indicating the best shares
Dividend Investing

Why this could be the best ASX dividend stock to buy today

There are few ideas that match this option for dividend investors.

Read more »

a pot of gold at the end of a rainbow
Dividend Investing

2 ASX shares I'm planning to own until I'm 100

These businesses have ultra-long-term prospects.

Read more »

Hand of a woman carrying a bag of money, representing the concept of saving money or earning dividends.
Dividend Investing

5 excellent ASX dividend stocks I would buy in 2026

These dividend stocks could be worth considering. Let's see why.

Read more »